Curriculum Vitaes
Profile Information
- Affiliation
- Graduate School of Medicine Program in Integrated Medicine Internal Medicine, Fujita Health University
- Degree
- Doctor of Philosophy for Medical Science(Nagoya University)
- J-GLOBAL ID
- 201001034860762065
- researchmap Member ID
- 1000314029
Research History
16-
Feb, 2020 - Present
-
Apr, 2017 - Aug, 2018
Education
2-
Apr, 2000 - Mar, 2004
-
Apr, 1987 - Mar, 1993
Committee Memberships
1-
Apr, 2019 - Present
Awards
1Papers
152-
Clinical and experimental nephrology, Apr 7, 2025BACKGROUND: IgA nephropathy (IgAN) is the most common type of primary glomerulonephritis. Elevation in the blood levels of aberrantly glycosylated IgA1 is a crucial initial step in IgAN pathogenesis. Here, we aimed to determine the longitudinal changes in the serum levels of IgA1 O- and N-glycoforms in patients with IgAN receiving different treatments. METHODS: We enrolled Japanese patients diagnosed with primary IgAN: 10 patients who underwent tonsillectomy and corticosteroid therapy (T-CST), 7 who received corticosteroid therapy (CST), 8 who received conservative therapy (CO), and 5 with other renal diseases who received corticosteroid therapy (ORD) as disease controls. IgA was purified from patient sera collected at diagnosis and post-treatment. After sample preparation, O-glycoforms of the hinge region (HR) and N-glycoforms of the fragment crystallizable region were analyzed using high-resolution mass spectrometry (MS). RESULTS: The MS analysis of O-glycoforms of IgA1 showed that the relative abundance of IgA1 with 3GalNAc3Gal, which we previously identified as a characteristic IgA1 O-glycoform in IgAN, decreased post-treatment only in the T-CST group (P = 0.0195). Regarding N-glycoforms, the relative abundance of fucosylated N-glycan at asparagine (Asn)340 increased in the IgAN group compared with that in the ORD group (P = 0.0189) and decreased post-treatment only in the T-CST group (P = 0.0195). CONCLUSION: The MS analysis of O- and N-glycoforms of IgA1 revealed substantial changes in their abundance in the T-CST group but not in the CST, CO, and ORD groups. Our study provides new insights into how specific treatments alter the IgA1 glycoform abundance.
-
Clinical Drug Investigation, Mar 13, 2025
-
Immunological medicine, 48(1) 47-57, Mar, 2025We compared different antineutrophil cytoplasmic antibody (ANCA) detection methods using a predominantly myeloperoxidase (MPO)-ANCA-associated vasculitis cohort. Stored sera from 147 patients with untreated ANCA-associated vasculitis (AAV), including microscopic polyangiitis and granulomatosis with polyangiitis (n = 115 and 32, respectively), and 124 disease controls were tested for P-ANCA and C-ANCA with immunofluorescence (IIF), and for MPO-ANCA and proteinase 3 (PR3)-ANCA with different antigen-specific immunoassays: direct enzyme-linked immunosorbent assay (ELISA), chemiluminescent enzyme immunoassay (CLEIA), third-generation fluorescent enzyme immunoassay (FEIA), and latex turbidimetrical immunoassay (LTIA). In addition, MPO-ANCA and PR3-ANCA titers were calibrated using certified reference materials (CRMs). The sensitivities and specificities for AAV diagnoses were 95% and 94% (IIF), 86% and 98% (ELISA), 93% and 94% (CLEIA), 92% and 96% (FEIA), and 68% and 88% (LTIA). Dual IIF/antigen-specific immunoassay testing reduced diagnostic accuracies from 94% to 93%. The quantitative agreement between ANCA levels measured using CLEIA and FEIA and calibrated using CRMs was not good. In conclusion, this study demonstrated the high performance of antigen-specific immunoassays for AAV diagnosis in a predominantly MPO-ANCA-associated vasculitis cohort and suggested that the benefit of dual IIF/antigen-specific immunoassay testing is limited. Standardizing ANCA measurements using different immunoassays was difficult, even when using CRMs.
-
Journal of clinical medicine, 14(3), Jan 21, 2025Background: Progression of chronic kidney disease (CKD) increases the risk of complications such as cardiovascular disease; however, knowledge regarding renal function in the general population is low. We aimed to determine factors necessitating CKD education in the general population. Methods: Participants for a health promotion seminar were recruited via the Sugiura Memorial Foundation website and Sugi Pharmacy stores. Those who agreed to participate in the seminar were included in the questionnaire survey after a health seminar. Results: Out of 1548 participants, 1050 answered all questionnaire items, resulting in a valid response rate of 67.83%. Multivariable analysis revealed that sex (OR = 0.611), pharmacy consultations (OR = 0.661), receiving a blood test within 1 year (OR = 0.268), awareness of blood pressure (OR = 0.038), and knowledge of blood glucose level (OR = 0.099) were factors for unawareness of renal function. Conclusions: This study suggests that female individuals unaware of their blood pressure or glucose levels, those who have not had a blood test within 1 year, and those who have not sought health consultations need education on renal function.
-
CEN CASE REPORTS, 13(5) 419-424, Oct, 2024
Misc.
165-
CELL TRANSPLANTATION, 22(2) 287-297, 2013 Peer-reviewed
-
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(6) 883-891, Dec, 2012 Peer-reviewed
-
BLOOD, 120(22) 4421-4431, Nov, 2012 Peer-reviewed
-
JOURNAL OF IMMUNOLOGY, 189(7) 3714-3723, Oct, 2012 Peer-reviewed
-
JOURNAL OF IMMUNOLOGY, 189(5) 2553-2562, Sep, 2012 Peer-reviewed
-
腎と透析, 73(別冊 腹膜透析2012) 235-236, Aug, 2012腹膜透析(PD)における小・中・大分子量物質除去と腹膜機能との関連性について検討した。PD患者51例を対象とした。小分子量物質D/P ureaは、D/P Crに比し溶質透過性は高く、相関を認めた。腹膜平衡試験(PET)4時間値でD/P=1となった症倒も認めた。D/P CrとD/P phosphate、D/P β2-MGは極めて強い有意な相関を認めた。D/P Crと大分子量物質の相関については、D/P Crと比較するといずれも大分子量物質の透過性は、低かったが、D/P Alb、D/P Tf、D/P IgG、α2-MGすべてにおいて、D/P Crと有意な相関を認めた。膜透析における溶質透過牲について、PETによる腹膜機能の把握は重要で、D/P Crで中分子量物質のD/P β2-MGの予測ができる可能性が示唆された。
-
NEPHROLOGY DIALYSIS TRANSPLANTATION, 27(6) 2511-2516, Jun, 2012 Peer-reviewed
-
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 16(3) 490-494, Jun, 2012 Peer-reviewed
-
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 15(6) 962-965, Dec, 2011 Peer-reviewed
-
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 15(3) 346-354, Jun, 2011 Peer-reviewed
-
XENOTRANSPLANTATION, 18(3) 196-208, May, 2011 Peer-reviewed
-
ARTHRITIS AND RHEUMATISM, 63(2) 467-478, Feb, 2011 Peer-reviewed
-
INTERNAL MEDICINE, 50(16) 1719-1723, 2011 Peer-reviewed
-
INTERNAL MEDICINE, 50(5) 471-474, 2011 Peer-reviewed
-
日本透析医学会雑誌, 43(Suppl.1) 377-377, May, 2010
-
CIRCULATION, 120(20) 2012-2024, Nov, 2009 Peer-reviewedInvited
-
CIRCULATION, 120(13) 1255-U144, Sep, 2009 Peer-reviewed
-
NEPHROLOGY, 13(5) 397-404, Aug, 2008 Peer-reviewed
-
IMMUNITY, 28(6) 833-846, Jun, 2008 Peer-reviewed
-
BLOOD, 111(7) 3591-3598, Apr, 2008 Peer-reviewed
-
JOURNAL OF IMMUNOLOGY, 179(11) 7466-7477, Dec, 2007 Peer-reviewed
-
ATHEROSCLEROSIS SUPPLEMENTS, 7(3) 168-168, Jun, 2006
Books and Other Publications
23Presentations
12-
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Jul 8, 2020BACKGROUND: The detection of leukocyte-derived CD11b (α subunit of integrin Mac-1) and CD163 (scavenger receptor) in urine may reflect renal inflammation in antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN). The objective of this study was to evaluate the clinical significance of urinary CD11b (U-CD11b) and CD163 (U-CD163) in ANCA-GN. METHODS: U-CD11b and U-CD163 were examined using enzyme-linked immunosorbent assay in ANCA-GN urine samples from our institutional cohort (n = 88) and a nationwide cohort (n = 138), and their association with renal histology was subsequently analyzed. Logistic regression analyses were performed on a nationwide ANCA cohort to determine the associations of the two urinary molecules with renal remission failure at 6 months or with yearly estimated glomerular filtration rate (eGFR) slope over a 24-month observation period. RESULTS: U-CD11b and U-CD163 were significantly associated with cellular crescent formation and leukocyte accumulation in glomerular crescents. With regard to interstitial inflammation, both levels of U-CD11b and U-CD163 at diagnosis remarkably increased in ANCA-GN compared with the levels observed in nonglomerular kidney disorders including nephrosclerosis, immunoglobulin G4-related disease and tubulointerstitial nephritis; however, the presence of U-CD11b alone was significantly correlated with tubulointerstitial leukocyte infiltrates. Although neither U-CD11b nor U-CD163 at diagnosis was associated with remission failure at 6 months, multivariate analysis demonstrated that the baseline U-CD11b levels were significantly associated with the increase in eGFR following immunosuppressive therapy. CONCLUSIONS: Although both U-CD11b and U-CD163 reflect renal leukocyte accumulation, U-CD11b at diagnosis provides additional clinical value by predicting the recovery rate after the treatment of ANCA-GN.
Professional Memberships
5Research Projects
18-
科学研究費助成事業, 日本学術振興会, Apr, 2025 - Mar, 2029
-
Elucidation of pathogenic IgA1 derived from palatine tonsils: towards the development of a biomarkerGrants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2025 - Mar, 2028
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2025 - Mar, 2028
-
Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, Apr, 2025 - Mar, 2028
-
科学研究費助成事業, 日本学術振興会, Apr, 2023 - Mar, 2026